Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
Go back to Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer| (NASDAQ: FRLN) | Delayed: 6.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.48 | 52 Week High | $ | |||
| Open | $3.18 | 52 Week Low | $ | |||
| Day High | $6.48 | P/E | N/A | |||
| Day Low | $6.48 | EPS | $ | |||
| Volume | 15,414 | |||||
| Kaleidoscope Venture Capital, Inc. (AMEX: KLDO) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.00 | |||
| Open | $0.00 | 52 Week Low | $0.00 | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $0.00 | |||
| Volume | 20 | |||||
